Software Healthcare Sector

Z Squared

Market Cap: US$193.5m

Operates as a computing and digital infrastructure company in North Carolina, South Carolina, and Iowa.

Exagen

Market Cap: US$191.9m

Designs, develops, and commercializes various testing products under the AVISE brand in the United States.

Protalix BioTherapeutics

Market Cap: US$191.8m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

Nkarta

Market Cap: US$190.5m

A clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment.

EDAP TMS

Market Cap: US$189.8m

EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally.

Armata Pharmaceuticals

Market Cap: US$189.6m

Operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide.

Mayne Pharma Group

Market Cap: AU$258.4m

A specialty pharmaceutical company, focuses on the commercialization of women’s health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.

Medical Facilities

Market Cap: CA$253.6m

Through its subsidiaries, owns and operates specialty surgical hospitals in the United States.

Lucid Diagnostics

Market Cap: US$184.1m

Operates as a commercial-stage medical diagnostics technology company in the United States.

Codexis

Market Cap: US$182.9m

Provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.

Quantum-Si

Market Cap: US$182.8m

A life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS).

Pacific Edge

Market Cap: NZ$304.3m

A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.

Happy Belly Food Group

Market Cap: CA$248.0m

Operates as a multi-branded restaurant company that engages in acquiring and scaling emerging food brands across Canada.

Humacyte

Market Cap: US$178.4m

Engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.

Caribou Biosciences

Market Cap: US$178.0m

Operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company.

Global Asset Management Group

Market Cap: US$175.9m

Operates as a diversified holding company focused on real estate and related business lines.

Organigram Global

Market Cap: CA$240.7m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

Healwell AI

Market Cap: CA$240.6m

Operates as a healthcare technology company in Canada, Australia, and New Zealand.

Canton Strategic Holdings

Market Cap: US$174.5m

Engages in the institutional blockchain adoption and digitization of financial markets in the United States.

Cue Biopharma

Market Cap: US$174.2m

A clinical-stage therapeutics company, focuses on developing various therapies for immunological disorders.

Indaptus Therapeutics

Market Cap: US$171.9m

A clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products.

Lifecore Biomedical

Market Cap: US$171.9m

Operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally.

MediWound

Market Cap: US$170.5m

A biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally.

Paragon Care

Market Cap: AU$231.7m

Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia.

Woodbrook Group Holdings

Market Cap: US$165.6m

Provides investment and strategic planning advisory services.

Jyong Biotech

Market Cap: US$161.8m

A science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia.

Scancell Holdings

Market Cap: UK£117.6m

A clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom.

Diaceutics

Market Cap: UK£117.6m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

OnKure Therapeutics

Market Cap: US$159.6m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases.

LifeMD

Market Cap: US$159.5m

Operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States.

USBC

Market Cap: US$159.5m

Operates in digital financial technologies business in United States.

Outlook Therapeutics

Market Cap: US$157.6m

Operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications.

Unicycive Therapeutics

Market Cap: US$156.8m

A clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States.

Tenaya Therapeutics

Market Cap: US$156.4m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

Hydreight Technologies

Market Cap: CA$214.1m

Operates in the digital health technology sector in the United States.

Orthocell

Market Cap: AU$216.4m

A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia and internationally.